Bio-Rad Infringed Three 10X Patents, Federal Circuit Affirms

April 29, 2021, 5:11 PM

Bio-Rad Laboratories Inc. can’t shake a trade agency ruling that it infringed three gene-sequencing patents owned by 10X Genomics Inc., the Federal Circuit ruled.

Bio-Rad argued it couldn’t infringe the patents because its former researchers, who left to form 10X, should be listed as co-inventors of the technology. The U.S. Court of Appeals for the Federal Circuit rejected that argument in a precedential opinion.

A contract that assigns all inventions made during employment with a company doesn’t reach inventions conceived after the term of the agreement, even if those inventions were based on work done while the employee was ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.